EGFR and glioblastoma: Genßler et al. (2015) [215] tested NK-92 cells expressing CAR with specificity to EGFR, EGFRvIII, or a shared epitope between these antigens, showing high NK cell cytotoxicity and specificity against primary GBM cells that expressed the antigens, as well as against GBM cell lines expressing EGFR and/or EGFRvIII.